MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PRCT had -$47,222K decrease in cash & cash equivalents over the period. -$58,341K in free cash flow.

Cash Flow Overview

Change in Cash
-$47,222K
Free Cash flow
-$58,341K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Stock-based compensation expense
    • Accounts payable
    • Depreciation and amortization
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Inventory
    • Purchases of property and equipm...
    • Others

Cash Flow
2025-12-31
Net loss
-95,572
Depreciation and amortization
6,390
Stock-based compensation expense
47,603
Change in fair value in derivative liability
0
Non-cash lease adjustment
508
Provision for credit losses
219
Inventory write-down
565
(gain) loss on foreign currency transactions
-157
Accounts receivable, net
898
Inventory
14,498
Prepaid expenses and other current assets
1,102
Other assets
2,895
Accounts payable
6,648
Accrued compensation
1,590
Accrued interest expense
142
Loan facility liability
-2,000
Deferred revenue
3,306
Reimbursements for leasehold improvements from operating leases
0
Other liabilities
1,868
Net cash used in operating activities
-48,985
Purchases of property and equipment
9,356
Net cash used in investing activities
-9,356
Proceeds from issuance of common stock under employee stock purchase plan
6,362
Proceeds from issuance of common stock from the exercise of stock options, net
4,831
Proceeds from issuance of common stock, net of issuance costs
0
Net cash provided by financing activities
11,193
Effect of exchange rates on cash, cash equivalents and restricted cash
-74
Net increase (decrease) in cash, cash equivalents and restricted cash
-47,222
Beginning of the period
336,763
End of the period
289,541
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofcommon stock under...$6,362K Proceeds from issuance ofcommon stock from the...$4,831K Net cash provided byfinancing activities$11,193K Net increase(decrease) in cash, cash...-$47,222K Canceled cashflow$11,193K Stock-based compensationexpense$47,603K Accounts payable$6,648K Depreciation andamortization$6,390K Deferred revenue$3,306K Other liabilities$1,868K Accrued compensation$1,590K Inventory write-down$565K Provision for creditlosses$219K (gain) loss on foreigncurrency transactions-$157K Accrued interestexpense$142K Net cash used inoperating activities-$48,985K Canceled cashflow$68,488K Net cash used ininvesting activities-$9,356K Effect of exchangerates on cash, cash...-$74K Net loss-$95,572K Inventory$14,498K Other assets$2,895K Loan facilityliability-$2,000K Prepaid expenses andother current assets$1,102K Accounts receivable, net$898K Non-cash leaseadjustment$508K Purchases of property andequipment$9,356K

PROCEPT BioRobotics Corp (PRCT)

PROCEPT BioRobotics Corp (PRCT)